Schatteman K - Search Results

1

Immunological assay for the determination of procarboxypeptidase U antigen levels in human plasma.

Strömqvist M, Schatteman K, Leurs J, Verkerk R, Andersson JO, Johansson T, Scharpé S, Hendriks D. Strömqvist M, et al. Among authors: schatteman k. Thromb Haemost. 2001 Jan;85(1):12-7. Thromb Haemost. 2001. PMID: 11204563

2

Plasma procarboxypeptidase U in men with symptomatic coronary artery disease.

Silveira A, Schatteman K, Goossens F, Moor E, Scharpé S, Strömqvist M, Hendriks D, Hamsten A. Silveira A, et al. Among authors: schatteman k. Thromb Haemost. 2000 Sep;84(3):364-8. Thromb Haemost. 2000. PMID: 11019956

3

Local proCPU (TAFI) activation during thrombolytic treatment in a dog model of coronary artery thrombosis can be inhibited with a direct, small molecule thrombin inhibitor (melagatran).

Mattsson C, Björkman JA, Abrahamsson T, Nerme V, Schatteman K, Leurs J, Scharpé S, Hendriks D. Mattsson C, et al. Among authors: schatteman k. Thromb Haemost. 2002 Apr;87(4):557-62. Thromb Haemost. 2002. PMID: 12008935

4

Activation of plasma procarboxypeptidase U in different mammalian species points to a conserved pathway of inhibition of fibrinolysis.

Schatteman KA, Goossens FJ, Scharpé SS, Hendriks DF. Schatteman KA, et al. Thromb Haemost. 1999 Dec;82(6):1718-21. Thromb Haemost. 1999. PMID: 10613660

5

Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma.

Leurs J, Wissing BM, Nerme V, Schatteman K, Björquist P, Hendriks D. Leurs J, et al. Among authors: schatteman k. Thromb Haemost. 2003 Feb;89(2):264-71. Thromb Haemost. 2003. PMID: 12574805

6

Carboxypeptidase U at the interface between coagulation and fibrinolysis.

Schatteman K, Goossens F, Leurs J, Verkerk R, Scharpé S, Michiels JJ, Hendriks D. Schatteman K, et al. Clin Appl Thromb Hemost. 2001 Apr;7(2):93-101. doi: 10.1177/107602960100700203. Clin Appl Thromb Hemost. 2001. PMID: 11292199 Free article. Review.

7

Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma.

Schatteman KA, Goossens FJ, Scharpé SS, Neels HM, Hendriks DF. Schatteman KA, et al. Clin Chem. 1999 Jun;45(6 Pt 1):807-13. Clin Chem. 1999. PMID: 10351989 Clinical Trial.

8

Proteolytic activation of purified human procarboxypeptidase U.

Schatteman KA, Goossens FJ, Scharpé SS, Hendriks DF. Schatteman KA, et al. Clin Chim Acta. 2000 Feb 25;292(1-2):25-40. doi: 10.1016/s0009-8981(99)00205-3. Clin Chim Acta. 2000. PMID: 10686274

9

Fast homogeneous assay for plasma procarboxypeptidase U.

Schatteman KA, Goossens FJ, Leurs J, Kasahara Y, Scharpé SS, Hendriks DF. Schatteman KA, et al. Clin Chem Lab Med. 2001 Sep;39(9):806-10. doi: 10.1515/CCLM.2001.133. Clin Chem Lab Med. 2001. PMID: 11601677

10

The gene for human carboxypeptidase U (CPU)--a proposed novel regulator of plasminogen activation--maps to 13q14.11.

Vanhoof G, Wauters J, Schatteman K, Hendriks D, Goossens F, Bossuyt P, Scharpé S. Vanhoof G, et al. Among authors: schatteman k. Genomics. 1996 Dec 15;38(3):454-5. doi: 10.1006/geno.1996.0656. Genomics. 1996. PMID: 8975730 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters